Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer Confirms Guidance Despite Net Profit Drop
02:03am, Tuesday, 13'th May 2025
The company stuck to its full-year outlook on better-than-expected sales and adjusted earnings, but posted a fall in net profit.
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
12:36pm, Monday, 12'th May 2025
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
Are Medical Stocks Lagging Bayer (BAYRY) This Year?
10:46am, Monday, 12'th May 2025
Here is how Bayer Aktiengesellschaft (BAYRY) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Bayer to Slash Hundreds of Jobs in Crop Division Overhaul
09:28am, Monday, 12'th May 2025
The company said it will discontinue certain production activities at its Dormagen and Frankfurt am Main sites.
Bayer U.S. Surveys Shed Further Light on the Diversity of Menopause Care Approaches and Menopause Symptom Experiences
10:25am, Thursday, 08'th May 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer U.S. Surveys Shed Further Light on the Diversity of Menopause Care Approaches and Menopause Symptom Experiences.
Don't Let Corn Rootworm Steal Your Yield: Bayer Launches The Watch 2025
08:00am, Monday, 05'th May 2025
ST. LOUIS--(BUSINESS WIRE)--Corn rootworm remains one of the most damaging pests in U.S. corn production, causing an estimated $1 billion in losses each year. To help farmers get ahead of this undergr
Plaintiffs' Attorneys Respond to Bayer's Threat to Pull Roundup from Market
04:56pm, Tuesday, 29'th Apr 2025
DALLAS--(BUSINESS WIRE)--Attorneys representing thousands of cancer victims criticized Bayer today for what they describe as an attempt to pressure courts, lawmakers and the public by threatening to p
Guru Ramamurthy Appointed as New CFO for Bayer's Crop Science Division
01:00am, Tuesday, 29'th Apr 2025
MONHEIM, Germany--(BUSINESS WIRE)--Bayer announced today that Guru Ramamurthy will become the new Chief Financial Officer (CFO) for Bayer's Crop Science division. He will succeed Oliver Rittgen who ha
World Bank adds Bayer, Hyatt and other CEOs to private sector initiative
01:04pm, Wednesday, 23'rd Apr 2025
The World Bank on Wednesday added four top executives, including Bayer AG CEO Bill Anderson and Hyatt Hotels CEO Mark Hoplamazian, to an initiative working to address barriers to private sector invest
ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
01:38pm, Tuesday, 22'nd Apr 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ -- powered by Guardant Health liquid biopsy genomic data -- and AI
Bayer CEO: targeting US state regulation to stem glyphosate costs
09:39am, Thursday, 17'th Apr 2025
Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weedkiller glyphosate, the German chemicals company's CEO said in a draft speec
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
02:41pm, Wednesday, 16'th Apr 2025
MYERSTOWN, Pa.--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This s
Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting
08:00am, Wednesday, 16'th Apr 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting.
Farmers' Favorite Weedkiller Nears Its End, Bayer Warns
09:00am, Monday, 14'th Apr 2025
The German company cites mounting costs from lawsuits blaming Roundup for causing cancer.
Bayer Obtains Full FDA Approval for Oncology Drug Vitrakvi
02:20pm, Friday, 11'th Apr 2025
The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from confirmatory studies.
